Vulnerability of β-Thalassemia Heterozygotes to COVID-19: Results from a Cohort Study.
Sotiriou S, Samara AA, Lachanas KE, Vamvakopoulou D, Vamvakopoulos KO, Vamvakopoulos N, Janho MB, Perivoliotis K, Donoudis C, Daponte A, Gourgoulianis KI, Boutlas S.
Sotiriou S, et al. Among authors: janho mb.
J Pers Med. 2022 Feb 25;12(3):352. doi: 10.3390/jpm12030352.
J Pers Med. 2022.
PMID: 35330352
Free PMC article.